A detailed history of Hartford Financial Management Inc. transactions in Incyte Corp stock. As of the latest transaction made, Hartford Financial Management Inc. holds 35 shares of INCY stock, worth $2,433. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Previous 35 -0.0%
Holding current value
$2,433
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

SELL
$52.16 - $64.19 $1,616 - $1,989
-31 Reduced 46.97%
35 $2,000
Q3 2022

Oct 25, 2022

SELL
$66.18 - $82.86 $794 - $994
-12 Reduced 15.38%
66 $4,000
Q1 2022

May 05, 2022

BUY
$66.02 - $79.71 $5,149 - $6,217
78 New
78 $6,000
Q1 2019

May 08, 2019

SELL
$63.56 - $88.17 $4,767 - $6,612
-75 Closed
0 $0
Q3 2018

Nov 01, 2018

BUY
$61.75 - $74.23 $4,631 - $5,567
75 New
75 $5,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Hartford Financial Management Inc. Portfolio

Follow Hartford Financial Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Financial Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hartford Financial Management Inc. with notifications on news.